Abstract
Purpose of Review
Sensory nerves (SNs) richly innervate bone and are a component of bone microenvironment. Cancer metastasis in bone, which is under the control of the crosstalk with bone microenvironment, induces bone pain via excitation of SNs innervating bone. However, little is known whether excited SNs in turn affect bone metastasis.
Recent Findings
Cancer cells colonizing bone promote neo-neurogenesis of SNs and excite SNs via activation of the acid-sensing nociceptors by creating pathological acidosis in bone, evoking bone pain. Denervation of SNs or inhibition of SN excitation decreases bone pain and cancer progression and increases survival in preclinical models. Importantly, patients with cancers with increased SN innervation complain of cancer pain and show poor outcome.
Summary
SNs establish the crosstalk with cancer cells to contribute to bone pain and cancer progression in bone. Blockade of SN excitation may have not only analgesic effects on bone pain but also anti-cancer actions on bone metastases.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584–93. https://doi.org/10.1038/nrc867.
Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655–64. https://doi.org/10.1056/NEJMra030831.
Yoneda T, Hiraga T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun. 2005;328:679–87. https://doi.org/10.1016/j.bbrc.2004.11.070.
Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11:411–25. https://doi.org/10.1038/nrc3055.
Johnson RW, Suva LJ. Hallmarks of bone metastasis. Calcif Tissue Int. 2017;102:141–51. https://doi.org/10.1007/s00223-017-0362-4.
Cooper RR. Nerves in cortical bone. Science. 1968;160:327–8.
Calvo W, Forteza-Vila J. On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. Am J Anat. 1969;126:355–71. https://doi.org/10.1002/aja.1001260308.
Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 2002;113:155–66.
Serre CM, Farlay D, Delmas PD, Chenu C. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone. 1999;25:623–9.
Irie K, Hara-Irie F, Ozawa H, Yajima T. Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech. 2002;58:85–90. https://doi.org/10.1002/jemt.10122.
Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006;7:797–809. https://doi.org/10.1038/nrn1914.
Mantyh PW. The neurobiology of skeletal pain. Eur J Neurosci. 2014;39:508–19. https://doi.org/10.1111/ejn.12462.
Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32:1647–54. https://doi.org/10.1200/JCO.2013.51.7219.
Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer. 2011;11:695–707. https://doi.org/10.1038/nrc3131.
Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H. Nerve-cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res. 2015;75:1777–81. https://doi.org/10.1158/0008-5472.
• Hiasa M, Okui T, Allette YM, et al. Bone pain induced by multiple myeloma is reduced by targeting V-ATPase and ASIC3. Cancer Res. 2017;77:1283–95. https://doi.org/10.1158/0008-5472 This paper shows that H + released by multiple myeloma cells induces CABP via activation of the acid-sensing nociceptor ASIC3 in mice.
• Wakabayashi H, Wakisaka S, Hiraga T, et al. Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice. J Bone Miner Metab. 2018;36:274–85. https://doi.org/10.1007/s00774-017-0842-7 This paper describes that genetic deletion of the acid-sensing nociceptor TRPV1 reduces CABP associated with Lewis lung cancer.
Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, et al. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer. 2013;119:832–8. https://doi.org/10.1002/cncr.27789.
von Moos R, Costa L, Ripamonti CI, Niepel D, Santini D. Improving quality of life in patients with advanced cancer: targeting metastatic bone pain. Eur J Cancer. 2017;71:80–94. https://doi.org/10.1016/j.ejca.2016.10.021.
Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature. 2013;497:490–3. https://doi.org/10.1038/nature12115.
Heffner MA, Anderson MJ, Yeh GC, Genetos DC, Christiansen BA. Altered bone development in a mouse model of peripheral sensory nerve inactivation. J Musculoskelet Neuronal Interact. 2014;14:1–9.
Ding Y, Arai M, Kondo H, Togari A. Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats. Bone. 2010;46:1591–6. https://doi.org/10.1016/j.bone.2010.02.022.
Alves CJ, Alencastre IS, Neto E, Ribas J, Ferreira S, Vasconcelos DM, et al. Bone injury and repair trigger central and peripheral NPY neuronal pathways. PLoS One. 2016;11:e0165465. https://doi.org/10.1371/journal.pone.0165465.
Burt-Pichat B, Lafage-Proust MH, Duboeuf F, Laroche N, Itzstein C, Vico L, et al. Dramatic decrease of innervation density in bone after ovariectomy. Endocrinology. 2005;146:503–10. https://doi.org/10.1210/en.2004-0884.
Nencini S, Ivanusic JJ. The physiology of bone pain. How much do we really know? Front Physiol. 2016;7:157. https://doi.org/10.3389/fphys.2016.00157.
•• Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–18 One of the earliest papers that describe and discuss about CABP.
Mantyh WG, Jimenez-Andrade JM, Stake JI, Bloom AP, Kaczmarska MJ, Taylor RN, et al. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience. 2010;171:588–98. https://doi.org/10.1016/j.neuroscience.2010.08.056.
Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW. Cancer-induced bone pain: mechanisms and models. Neurosci Lett. 2013;557(Pt A):52–9. https://doi.org/10.1016/j.neulet.2013.08.003.
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139:267–84. https://doi.org/10.1016/j.cell.2009.09.028.
Krames ES. The dorsal root ganglion in chronic pain and as a target for neuromodulation: a review. Neuromodulation. 2015;18:24–32; discussion. https://doi.org/10.1111/ner.12247.
Abdelhamid RE, Sluka KA. ASICs mediate pain and inflammation in musculoskeletal diseases. Physiology (Bethesda, Md). 2015;30:449–59. https://doi.org/10.1152/physiol.00030.2015.
Maes C, Carmeliet G, Schipani E. Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol. 2012;8:358–66. https://doi.org/10.1038/nrrheum.2012.36.
Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol. 2008;9:285–96. https://doi.org/10.1038/nrm2354.
Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov. 2011;10:767–77. https://doi.org/10.1038/nrd3554.
Parks SK, Chiche J, Pouyssegur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer. 2013;13:611–23. https://doi.org/10.1038/nrc3579.
• Devignes CS, Aslan Y, Brenot A, et al. HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice. Proc Natl Acad Sci U S A. 2018;115:E992–e1001. https://doi.org/10.1073/pnas.1718009115 This paper shows that HIF in osteoblasts systemically modulates breast cancer progression via increasing CXCL12 secretion by osteoblasts.
Di Pompo G, Lemma S, Canti L, et al. Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma. Oncotarget. 2017;8:54478–96. https://doi.org/10.18632/oncotarget.17091.
Terpos E, Christoulas D, Gavriatopoulou M. Biology and treatment of myeloma related bone disease. Metabolism. 2017;80:80–90. https://doi.org/10.1016/j.metabol.2017.11.012.
Qin A, Cheng TS, Pavlos NJ, Lin Z, Dai KR, Zheng MH. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Int J Biochem Cell Biol. 2012;44:1422–35. https://doi.org/10.1016/j.biocel.2012.05.014.
Maeda H, Kowada T, Kikuta J, Furuya M, Shirazaki M, Mizukami S, et al. Real-time intravital imaging of pH variation associated with osteoclast activity. Nat Chem Biol. 2016;12:579–85. https://doi.org/10.1038/nchembio.2096.
Holzer P. Acid sensing by visceral afferent neurones. Acta Physiol (Oxford). 2011;201:63–75. https://doi.org/10.1111/j.1748-1716.2010.02143.x.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306–13.
Ghilardi JR, Rohrich H, Lindsay TH, et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci. 2005;25:3126–31. https://doi.org/10.1523/jneurosci.3815-04.2005.
Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience. 2007;148:560–72. https://doi.org/10.1016/j.neuroscience.2007.05.049.
Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br J Anaesth. 2009;102:251–8. https://doi.org/10.1093/bja/aen347.
Xu Q, Zhang XM, Duan KZ, Gu XY, Han M, Liu BL, et al. Peripheral TGF-beta1 signaling is a critical event in bone cancer-induced hyperalgesia in rodents. J Neurosci. 2013;33:19099–111. https://doi.org/10.1523/jneurosci.4852-12.2013.
Li Y, Cai J, Han Y, Xiao X, Meng XL, Su L, et al. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Eur J Pain. 2014;18:774–84. https://doi.org/10.1002/j.1532-2149.2013.00420.x.
Fang D, Kong LY, Cai J, et al. Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model. Pain. 2015;156:1124–44. https://doi.org/10.1097/j.pain.0000000000000158.
Nagae M, Hiraga T, Wakabayashi H, Wang L, Iwata K, Yoneda T. Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone. 2006;39:1107–15. https://doi.org/10.1016/j.bone.2006.04.033.
Shepherd AJ, Mickle AD, Kadunganattil S, Hu H, Mohapatra DP. Parathyroid hormone-related peptide elicits peripheral TRPV1-dependent mechanical hypersensitivity. Front Cell Neurosci. 2018;12:38. https://doi.org/10.3389/fncel.2018.00038.
Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436:193–200. https://doi.org/10.1038/nature03875.
Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693–705.
Quaegebeur A, Lange C, Carmeliet P. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron. 2011;71:406–24. https://doi.org/10.1016/j.neuron.2011.07.013.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. https://doi.org/10.1016/j.cell.2011.02.013.
Hanoun M, Maryanovich M, Arnal-Estape A, Frenette PS. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron. 2015;86:360–73. https://doi.org/10.1016/j.neuron.2015.01.026.
Saloman JL, Albers KM, Rhim AD, Davis BM. Can stopping nerves, stop cancer? Trends Neurosci. 2016;39:880–9. https://doi.org/10.1016/j.tins.2016.10.002.
Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer. 2015;15:563–72. https://doi.org/10.1038/nrc3978.
Marchesi F, Piemonti L, Mantovani A, Allavena P. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 2010;21:77–82. https://doi.org/10.1016/j.cytogfr.2009.11.001.
• Elefteriou F. Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone. J Bone Oncol. 2016;5:132–4. https://doi.org/10.1016/j.jbo.2016.03.003 This is a concise review on the role of sympathetic nerves in bone metastasis of breast cancer.
Zong JC, Wang X, Zhou X, et al. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice. Oncol Rep. 2016;35:739–48. https://doi.org/10.3892/or.2015.4430.
•• Magnon C, Hall SJ, Lin J, et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361. https://doi.org/10.1126/science.1236361 A pioneering paper that first shows the critical role of autonomic nerves in prostate cancer progression and metastases in preclinical models.
• Zhao CM, Hayakawa Y, Kodama Y, et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6:250ra115. https://doi.org/10.1126/scitranslmed.3009569 This paper proposes that denervation is a potential therpaeutic approach for gastric cancer in mice.
•• Saloman JL, Albers KM, Li D, et al. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Proc Natl Acad Sci U S A. 2016;113:3078–83. https://doi.org/10.1073/pnas.1512603113 A pioneering paper first showing the results that sensory nerves play a role in the progression of pacreatic cancer using genetically-modified mice.
• Li J, Sun Y, Ding G, Jiang F. Persistent pain accelerates xenograft tumor growth of breast cancer in rat. Biochem Biophys Res Commun. 2018;495:2432–8. https://doi.org/10.1016/j.bbrc.2017.12.121 This paper describes the effects of pain on tumor growth.
Jung WC, Levesque JP, Ruitenberg MJ. It takes nerve to fight back: the significance of neural innervation of the bone marrow and spleen for immune function. Semin Cell Dev Biol. 2017;61:60–70. https://doi.org/10.1016/j.semcdb.2016.08.010.
Elefteriou F. Impact of the autonomic nervous system on the skeleton. Physiol Rev. 2018;98:1083–112. https://doi.org/10.1152/physrev.00014.2017.
Campbell JP, Karolak MR, Ma Y, Perrien DS, Masood-Campbell SK, Penner NL, et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 2012;10:e1001363. https://doi.org/10.1371/journal.pbio.1001363.
• Mulcrone PL, Campbell JP, Clement-Demange L, et al. Skeletal colonization by breast cancer cells is stimulated by an osteoblast and beta2AR-dependent neo-angiogenic switch. J Bone Miner Res. 2017;32:1442–54. https://doi.org/10.1002/jbmr.3133 This paper shows that beta2-adrenergic receptors in osteoblasts stimulate bone metastases of breast cancer via promotion of neoangiogenesis.
Jimenez-Andrade JM, Ghilardi JR, Castaneda-Corral G, Kuskowski MA, Mantyh PW. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain. 2011;152:2564–74. https://doi.org/10.1016/j.pain.2011.07.020.
McCaffrey G, Thompson ML, Majuta L, Fealk MN, Chartier S, Longo G, et al. NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use. Cancer Res. 2014;74:7014–23. https://doi.org/10.1158/0008-5472.can-14-1220.
Halabi S, Vogelzang NJ, Kornblith AB, Ou SS, Kantoff PW, Dawson NA, et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol. 2008;26:2544–9. https://doi.org/10.1200/jco.2007.15.0367.
• Saad F, Carles J, Gillessen S, et al. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. Lancet Oncol. 2016;17:1306–16. https://doi.org/10.1016/s1470-2045(16)30173-5 A clinical paper that shows a correlation between the degree of CABP and survicval in patients with castration-resisitant prostate cancer.
Mancino M, Ametller E, Gascon P, Almendro V. The neuronal influence on tumor progression. Biochim Biophys Acta. 2011;1816:105–18. https://doi.org/10.1016/j.bbcan.2011.04.005.
Patel MK, Kaye AD, Urman RD. Tanezumab: therapy targeting nerve growth factor in pain pathogenesis. J Anaesthesiol Clin Pharmacol. 2018;34:111–6. https://doi.org/10.4103/joacp.JOACP_389_15.
Ozsvari B, Lamb R, Lisanti MP. Repurposing of FDA-approved drugs against cancer - focus on metastasis. Aging. 2016;8:567–8. https://doi.org/10.18632/aging.100941.
• Friedman JR, Nolan NA, Brown KC, et al. Anticancer activity of natural and synthetic capsaicin analogs. J Pharmacol Exp Ther. 2018;364:462–73. https://doi.org/10.1124/jpet.117.243691 A review paper describing the potential of capsaicin as an anti-cancer agent.
Farfariello V, Liberati S, Morelli MB, Tomassoni D, Santoni M, Nabissi M, et al. Resiniferatoxin induces death of bladder cancer cells associated with mitochondrial dysfunction and reduces tumor growth in a xenograft mouse model. Chem Int. 2014;224:128–35. https://doi.org/10.1016/j.cbi.2014.10.020.
Eng JW, Reed CB, Kokolus KM, et al. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through beta2-adrenergic receptor activation. Nat Commun. 2015;6:6426. https://doi.org/10.1038/ncomms7426.
Funding
The studies described in this review were partly supported by the Project Development Team within the ICTSI NIH/NCRR (#TR000006), start-up fund of Indiana University School of Medicine and Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#17H04377).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Additional information
This article is part of the Topical Collection on Cancer-induced Musculoskeletal Diseases
Rights and permissions
About this article
Cite this article
Yoneda, T., Hiasa, M. & Okui, T. Crosstalk Between Sensory Nerves and Cancer in Bone. Curr Osteoporos Rep 16, 648–656 (2018). https://doi.org/10.1007/s11914-018-0489-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-018-0489-x